Dr. David L. Bartlett

James Marsh is a Transplant Surgeon and a General Surgeon in Morgantown, West Virginia. Dr. Marsh has been practicing medicine for over 46 years and is rated as an Advanced provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Cholestasis, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Embolization, and Hepatectomy. Dr. Marsh is currently accepting new patients.

Kyle Soltys, MD, is a board-certified pediatric liver transplant surgeon at UPMC Children’s Hospital of Pittsburgh and an associate professor of Surgery at the University of Pittsburgh School of Medicine. Dr. Soltys earned his medical degree from the Boston University School of Medicine. He then completed a General Surgery Residency at the University Hospital Department of Surgery in Newark, NJ, followed by a Transplant Fellowship at Mount Sinai Medical Center, Recanati-Miller Transplant Institute. Finally, he completed a Transplantation Fellowship at UPMC’s Thomas E. Starzl Transplant Institute. His research and clinical interests include late graft loss in pediatric transplantation, infectious complications of pediatric transplant, ischemia/reperfusion injury in fatty liver models, preservation injury and post-transplant lymphoproliferative disorders. View Dr. Soltys' full list of publications from PubMed. Dr. Soltys is rated as an Advanced provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Crigler-Najjar Syndrome, Cholestasis, Progressive Familial Intrahepatic Cholestasis Type 1, Liver Transplant, and Small Bowel Resection.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Cholestasis. His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.